Interim update on batch 2367047 of Rovacor® tablets 20mg (lovastatin) (SIN 10531P)

Ranbaxy (Malaysia) Sdn. Bhd., in consultation with the Health Sciences Authority (HSA) would like to alert healthcare professionals of the voluntary recall of Rovacor^® Tablets 20mg (Batch number 2367047) due to a mix-up. The root cause of this mix-up is still under investigations by Ranbaxy and HSA. The affected batch has also been quarantined since 7 December 2012. Ranbaxy will also conduct visual inspections on replacement batches of tablets. In addition, it is recommended that healthcare professionals and dispensers also conduct a visual check on the replaced batches of Rovacor^® tablets 20mg. Healthcare professionals will be updated on the investigation outcome once it is completed. Please refer to the letter for more details.

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg ↗ (opens in new tab) and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under ‘For Healthcare Professionals’.

Step 2: Click on ‘Useful links’.

Step 3: Click on ‘MOH Alert’ and log in via Singpass.

Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.